In final draft guidance, UK drugs watchdog the National Institute for Health and Care Excellence (NICE) has recommended the use of French drug major Sanofi subsidiary Genzyme's multiple sclerosis drug Lemtrada (alemtuzumab).
NICE is appraising alemtuzumab as a treatment for adults with relapsing & remitting multiple sclerosis, a chronic and disabling neurological condition that, as it progresses, can have a substantial negative impact on a person’s quality of life........ Read More - http://www.ms-uk.org/lemtrada
NICE says 'yes' to Genzyme's MS drug Lemtrada
NICE says 'yes' to Genzyme's MS drug Lemtrada
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
-
Third course of Lemtrada improves MS patient’s relapse rate
by MSUK » Mon Mar 05, 2018 8:27 am » in Campath (Lemtrada, Alemtuzumab) - 0 Replies
- 2478 Views
-
Last post by MSUK
Mon Mar 05, 2018 8:27 am
-
-
-
NICE proposes the withdrawal of six disease modifying drugs
by MSUK » Thu Dec 21, 2017 3:47 am » in General Discussion - 1 Replies
- 705 Views
-
Last post by jimmylegs
Thu Dec 21, 2017 6:10 am
-
-
-
Lemtrada (alemtuzumab) FDA issues risk of stroke warning
by Scott1 » Thu Nov 29, 2018 8:20 pm » in Campath (Lemtrada, Alemtuzumab) - 0 Replies
- 1784 Views
-
Last post by Scott1
Thu Nov 29, 2018 8:20 pm
-
-
-
Lemtrada (alemtuzumab) FDA issues risk of stroke warning
by Scott1 » Thu Nov 29, 2018 8:20 pm » in General Discussion - 0 Replies
- 1005 Views
-
Last post by Scott1
Thu Nov 29, 2018 8:20 pm
-
-
- 1 Replies
- 849 Views
-
Last post by NHE
Wed Feb 07, 2018 11:27 pm
-
- 9 Replies
- 3482 Views
-
Last post by ElliotB
Wed Jan 09, 2019 1:55 pm
-
- 0 Replies
- 794 Views
-
Last post by seeva
Sat Dec 22, 2018 11:47 pm
-
- 0 Replies
- 308 Views
-
Last post by ElliotB
Mon Mar 18, 2019 4:29 pm
-
-
Risks associated between MS drug natalizumab and pregnancy
by MSUK » Tue Feb 20, 2018 5:44 am » in Tysabri (Antegren or Natalizumab) - 0 Replies
- 1398 Views
-
Last post by MSUK
Tue Feb 20, 2018 5:44 am
-
